Literature DB >> 26671108

No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir Valley of India.

Insha Zahoor1, Ravouf Asimi2, Ehtishamul Haq3.   

Abstract

Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the nervous system with a profound genetic element. It is already known that alterations in Eukaryotic Translation Initiation Factor 2B (EIF2B) gene encoding the five subunits of eIF2B complex cause Vanishing White Matter (VWM) disease of the brain and emerging evidences have advocated certain resemblances between MS and VWM in terms of clinical and epidemiological characteristics, thus validating the association study between EIF2B and MS. Moreover, a recent study has implicated EIF2B5 Ile587Val (rs843358) polymorphism as a susceptibility factor for MS. In order to investigate the association of EIF2B5 Ile587Val polymorphism with MS susceptibility in Kashmir region in India, we screened EIF2B5 Exon 13 in 30 MS patients and 65 controls (a total of 95 participants). During the present course of study, we could not find statistically significant difference in the frequency of Ile587Val between MS patients and controls, thus indicating that such alteration does not appear to influence MS development in Kashmiri population. Our results provide evidence against a major role for Ile587Val polymorphism in MS susceptibility.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Environmental risk factors.; Kashmiri population.; Multiple sclerosis.; Polymorphism.; Vanishing white matter disease.

Mesh:

Substances:

Year:  2015        PMID: 26671108     DOI: 10.1016/j.jns.2015.11.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Multiple Sclerosis in India.

Authors:  Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383

2.  Low EIF2B5 expression predicts poor prognosis in ovarian cancer.

Authors:  Lin Hou; Yan Jiao; Yanqing Li; Zhangping Luo; Xueying Zhang; Guoqiang Pan; Yuechen Zhao; Zhaoying Yang; Miao He
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.